Core Scientific (CORZ) Capital Expenditures (2021 - 2026)

Core Scientific has disclosed Capital Expenditures across 6 years of filings, most recently posting $389.2 million for Q1 2026.

• Capital Expenditures for Q1 2026 came in at $389.2 million, up 363.47% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.0 billion (up 478.23% YoY), and the FY2025 annual result was $729.0 million, up 667.68% from the prior year.
• Capital Expenditures came in at $389.2 million for Q1 2026 at Core Scientific, up from $279.2 million in the prior quarter.
• In the past five years, Capital Expenditures ranged from a high of $389.2 million in Q1 2026 to a low of -$62.3 million in Q4 2022.
• The 5-year median for Capital Expenditures is $22.5 million (2022), against an average of $83.0 million.
• Across the five-year window, Capital Expenditures sank 99.89% in 2023 and jumped 247408.16% in 2025, its largest moves.
• Core Scientific's Capital Expenditures stood at -$62.3 million in 2022, then jumped by 118.68% to $11.6 million in 2023, then jumped by 146.96% to $28.8 million in 2024, then jumped by 871.03% to $279.2 million in 2025, then jumped by 39.38% to $389.2 million in 2026.
• The last three Capital Expenditures figures came in at $389.2 million (Q1 2026), $279.2 million (Q4 2025), and $244.5 million (Q3 2025), per Business Quant data.